A new method of Wilms' tumor gene WT1 quantitative assay (WT1 assay) based on real-time PCR for the detection of minimal residual disease (MRD) in patients with leukemia and myelodysplastic syndromes (MDS)

被引：0

作者：

Tamaki, H

Ogawa, H

Oka, Y

Soma, T

Sugiyama, H

机构：

[1] Osaka Univ, Grad Sch Med, Dept Mol Med, Suita, Osaka 565, Japan

[2] Osaka Univ, Grad Sch Med, Dept Clin Lab Sci, Suita, Osaka 565, Japan

[3] Osaka Minami Natl Hosp, Dept Med, Osaka, Japan

来源：

LEUKEMIA | 2001年 / 15卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2024 / 2024

页数：1

共 50 条

[1] Wilms tumor gene (WT1) as a new marker for the detection of minimal residual disease in leukemia
Sugiyama, H
LEUKEMIA & LYMPHOMA, 1998, 30 (1-2) : 55 - 61
[2] Monitoring minimal residual disease in leukemia using real-time quantitative polymerase chain reaction for Wilms tumor gene (WT1)
Tamaki, H
Mishima, M
Kawakami, M
Tsuboi, A
Kim, EH
Hosen, N
Ikegame, K
Murakami, M
Fujioka, T
Masuda, T
Taniguchi, Y
Nishida, S
Osumi, K
Soma, T
Oji, Y
Oka, Y
Kawase, I
Sugiyama, H
Ogawa, H
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (04) : 349 - 356
[3] Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)
Hiroya Tamaki
Machiko Mishima
Manabu Kawakami
Akihiro Tsuboi
Eui Ho Kim
Naoki Hosen
Kazuhiro Ikegame
Masaki Murakami
Tatsuya Fujioka
Tomoki Masuda
Yuki Taniguchi
Sumiyuki Nishida
Kazuoki Osumi
Toshihiro Soma
Yusuke Oji
Yoshihiro Oka
Ichiro Kawase
Haruo Sugiyama
Hiroyasu Ogawa
International Journal of Hematology, 2003, 78 : 349 - 356
[4] Quantitative analysis of WT1 gene for detection of minimal residual disease in acute leukemia by real-time RT-PCR
Ghaffari, S. H.
Hemmati, T.
Rostami, S.
Alimoghaddam, K.
Ghavamzadeh, A.
EJC SUPPLEMENTS, 2005, 3 (02): : 285 - 285
[5] Comparison of minimal residual disease (MRD) estimated by flow cytometry and by real-time quantitative PCR of Wilms tumor gene 1 (WT1) transcript expression in children with acute lymphoblastic leukemia
Chen, Jiann-Shiuh
Hsiao, Chih-Cheng
Sheen, Jiunn-Ming
Cheng, Chao-Neng
LEUKEMIA RESEARCH, 2007, 31 (10) : 1351 - 1357
[6] Detection of minimal residual disease (MRD) in peripheral blood (PB) of patients with leukemia measuring the wilms tumor 1 (WT1) gene expression by a semi-quantitative RT-PCR.
Morris, K
Chou, P
Wang, LJ
Huang, W
Olszewski, M
BLOOD, 1999, 94 (10) : 209B - 209B
[7] WT1 Monitoring of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia
Malagola, Michele
Skert, Crisitina
Morello, Enrico
Antoniazzi, Francesca
Borlenghi, Erika
Turra, Alessandro
Pagani, Chiara
Ribolla, Rossella
Cancelli, Valeria
Cattina, Federica
Alghisi, Elisa
Bernardi, Simona
Perucca, Simone
Di Palma, Andrea
Ruggeri, Giuseppina
Rossi, Giuseppe
Caimi, Luigi
Russo, Domenico
BLOOD, 2014, 124 (21)
[8] The Wilms’ tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes
H Tamaki
H Ogawa
K Ohyashiki
JH Ohyashiki
H Iwama
K Inoue
T Soma
Y Oka
T Tatekawa
Y Oji
A Tsuboi
EH Kim
M Kawakami
K Fuchigami
M Tomonaga
K Toyama
K Aozasa
T Kishimoto
H Sugiyama
Leukemia, 1999, 13 : 393 - 399
[9] The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes
Tamaki, H
Ogawa, H
Ohyashiki, K
Ohyashiki, JH
Iwama, H
Inoue, K
Soma, T
Oka, Y
Tatekawa, T
Oji, Y
Tsuboi, A
Kim, EH
Kawakami, M
Fuchigami, K
Tomonaga, M
Toyama, K
Aozasa, K
Kishimoto, T
Sugiyama, H
LEUKEMIA, 1999, 13 (03) : 393 - 399
[10] Real-time quantitative PCR (RQ-PCR) detection of minimal residual disease (MRD) by optimized WT1 assay to enhance risk stratification in acute myeloid leukemia (AML):: A European leukemia net study.
Cilloni, Daniela
Renneville, A.
Hermitte, F.
Hills, R. K.
Daly, S.
Jovanovic, J.
Gottardi, E.
Fava, M.
Schnittger, S.
Izzo, B.
Nomdedeu, J.
Van der Heijden, A.
Van der Velden, V.
Rohon, P.
Ommen, H.
Polak, J.
Jansen, J.
Preudhomme, C.
Saglio, G.
Grimwade, D.
BLOOD, 2007, 110 (11) : 167A - 167A

← 1 2 3 4 5 →